Strategic shift to fully focus on ReNeuron’s Proprietary Exosomes Platform
04 July 2022: ReNeuron Group plc (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces its preliminary results for the year ended 31 March 2022.